Halozyme Therapeutics
HALO
Hutchmed (China)
HCM
Teradata Corp
TDC
Dorian LPG
LPG
LIFE HEALTHCARE GROUP HOLDINGS UNSPON ADR EA REPR 4 ORD ZAR0.00
LTGHY
(Q3)Sep 30, 2024 | (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q3)Sep 30, 2023 | (Q2)Jun 30, 2023 | (Q1)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q4)Dec 31, 2022 | |
---|---|---|---|---|---|---|---|---|---|---|
Total revenue | 1.1M | 900K | 500K | 0 | 0 | 0 | 0 | 0 | 11.45%13.83M | 0 |
Operating revenue | --1.1M | --900K | --500K | --0 | --0 | --0 | --0 | --0 | 11.45%13.83M | --0 |
Cost of revenue | 0 | -11.23%6.71M | 0 | |||||||
Gross profit | 0 | 46.86%7.11M | 0 | |||||||
Operating expense | 13.03%66.65M | 10.03%63.89M | 25.97%56M | 45.46%222.37M | 42.88%60.88M | 39.98%58.97M | 64.02%58.07M | 35.78%44.45M | 66.92%152.88M | 36.30%42.61M |
Selling and administrative expenses | 41.44%15.55M | 74.53%17.84M | 24.65%12.29M | -13.93%41.6M | -1.59%10.53M | -14.87%11M | -21.83%10.22M | -15.16%9.86M | 35.63%48.33M | -7.82%10.7M |
-General and administrative expense | 41.44%15.55M | 74.53%17.84M | 24.65%12.29M | -13.93%41.6M | -1.59%10.53M | -14.87%11M | -21.83%10.22M | -15.16%9.86M | 35.63%48.33M | -7.82%10.7M |
Research and development costs | 26.30%36.55M | -23.93%25.66M | -27.68%23.77M | 26.51%126.3M | 0.34%30.76M | 3.23%28.94M | 59.54%33.73M | 64.15%32.86M | 88.22%99.83M | 63.14%30.66M |
Depreciation amortization depletion | -23.57%14.54M | 44.47%20.39M | 1,050.89%19.95M | 1,056.21%54.47M | 1,462.36%19.59M | 1,523.63%19.03M | 1,091.14%14.12M | 57.55%1.73M | 61.72%4.71M | 45.14%1.25M |
-Depreciation and amortization | -23.57%14.54M | 44.47%20.39M | 1,050.89%19.95M | 1,056.21%54.47M | 1,462.36%19.59M | 1,523.63%19.03M | 1,091.14%14.12M | 57.55%1.73M | 61.72%4.71M | 45.14%1.25M |
Operating profit | -11.16%-65.55M | -8.48%-62.99M | -24.85%-55.5M | -52.55%-222.37M | -42.88%-60.88M | -45.66%-58.97M | -91.38%-58.07M | -37.49%-44.45M | -68.04%-145.76M | -49.60%-42.61M |
Net non-operating interest income expense | -380.00%-1.39M | -229.81%-2.24M | -206.16%-2.22M | 1.60%2.68M | -1.64M | 495K | 1.72M | 2.09M | 2.63M | |
Non-operating interest income | ---- | ---- | ---- | 1.60%2.68M | ---- | ---- | ---- | ---- | --2.63M | ---- |
Total other finance cost | 380.00%1.39M | 229.81%2.24M | 206.16%2.22M | ---- | ---- | ---495K | ---1.72M | ---2.09M | ---- | ---- |
Other net income (expense) | -3,048.20%-235.5M | -1,204.02%-65.89M | 764.91%18.21M | -103.21%-1.3M | -184.86%-12.52M | -11.03%7.99M | -73.32%5.97M | 49.90%-2.74M | 194.12%40.64M | -7.41%14.76M |
Gain on sale of security | -3,266.85%-236.91M | -1,121.47%-66.14M | 142.92%18.21M | -52.99%8.99M | -171.47%-12.47M | 147.06%7.48M | -71.91%6.48M | 236.77%7.5M | 21.24%19.11M | -3.31%17.45M |
Other non- operating income (expenses) | 178.11%1.41M | 149.70%252K | 99.98%-2K | -147.81%-10.29M | 98.03%-53K | -97.96%507K | 25.33%-507K | -68,346.67%-10.24M | 1,203.64%21.52M | -27.73%-2.69M |
Income before tax | -499.09%-302.43M | -160.27%-131.12M | 12.39%-39.51M | -115.61%-221M | -197.53%-75.04M | -60.25%-50.48M | -531.94%-50.38M | -19.32%-45.1M | -40.54%-102.5M | -101.03%-25.22M |
Income tax | 142.86%646K | 129.28%231K | 153.45%294K | 172.45%1.68M | 1,706.92%2.09M | -51.64%266K | -921.88%-789K | 11.54%116K | 86.40%617K | -150.39%-130K |
Net income | -497.23%-303.08M | -164.88%-131.35M | 11.97%-39.8M | -115.95%-222.68M | -207.40%-77.12M | -58.33%-50.75M | -514.64%-49.59M | -19.29%-45.22M | -40.75%-103.11M | -95.96%-25.09M |
Net income continuous Operations | -497.23%-303.08M | -164.88%-131.35M | 11.97%-39.8M | -115.95%-222.68M | -207.40%-77.12M | -58.33%-50.75M | -514.64%-49.59M | -19.29%-45.22M | -40.75%-103.11M | -95.96%-25.09M |
Minority interest income | -339.47%-131.13M | -88.58%-58.8M | 30.53%-20.07M | -89.04%-135.12M | -168.08%-45.2M | -33.89%-29.84M | -506.16%-31.18M | -6.31%-28.9M | -31.66%-71.47M | 20.74%-16.86M |
Net income attributable to the parent company | -722.35%-171.95M | -294.12%-72.55M | -20.91%-19.73M | -176.74%-87.56M | -287.97%-31.93M | -114.10%-20.91M | -529.55%-18.41M | -52.21%-16.32M | -66.76%-31.64M | -197.15%-8.23M |
Preferred stock dividends | ||||||||||
Other preferred stock dividends | ||||||||||
Net income attributable to common stockholders | -722.35%-171.95M | -294.12%-72.55M | -20.91%-19.73M | -176.74%-87.56M | -287.97%-31.93M | -114.10%-20.91M | -529.55%-18.41M | -52.21%-16.32M | -66.76%-31.64M | -164.60%-8.23M |
Basic earnings per share | -378.26%-1.1 | -112.50%-0.51 | 30.43%-0.16 | -84.48%-1.07 | -184.62%-0.37 | -27.78%-0.23 | -300.00%-0.24 | -9.52%-0.23 | -56.76%-0.58 | -116.24%-0.13 |
Diluted earnings per share | -378.26%-1.1 | -112.50%-0.51 | 30.43%-0.16 | -84.48%-1.07 | -184.62%-0.37 | -27.78%-0.23 | -300.00%-0.24 | -9.52%-0.23 | -56.76%-0.58 | -116.24%-0.13 |
Dividend per share | ||||||||||
Currency Unit | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
Audit Opinions | -- | -- | -- | Unqualified Opinion | -- | -- | -- | -- | Unqualified Opinion | -- |